vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and MetroCity Bankshares, Inc. (MCBS). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $43.7M, roughly 1.4× MetroCity Bankshares, Inc.). MetroCity Bankshares, Inc. runs the higher net margin — 50.5% vs -70.9%, a 121.4% gap on every dollar of revenue. On growth, MetroCity Bankshares, Inc. posted the faster year-over-year revenue change (23.6% vs 8.1%). MetroCity Bankshares, Inc. produced more free cash flow last quarter ($37.0M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 15.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Metro City Bank is a Korean-American bank based in Doraville, Georgia and offers personal and commercial banking services. It is the largest Korean-American bank to not be based out of Los Angeles, California. It currently operates a total of 19 branches in Texas, New York, New Jersey, Virginia, Georgia, Alabama, and Florida.
CTKB vs MCBS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $43.7M |
| Net Profit | $-44.1M | $18.1M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 52.8% |
| Net Margin | -70.9% | 50.5% |
| Revenue YoY | 8.1% | 23.6% |
| Net Profit YoY | -557.1% | 11.7% |
| EPS (diluted) | — | $0.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $43.7M | ||
| Q3 25 | $52.3M | $38.0M | ||
| Q2 25 | $45.6M | $37.9M | ||
| Q1 25 | $41.5M | $36.0M | ||
| Q4 24 | $57.5M | $35.4M | ||
| Q3 24 | $51.5M | $36.9M | ||
| Q2 24 | $46.6M | $36.3M | ||
| Q1 24 | $44.9M | $32.7M |
| Q4 25 | $-44.1M | $18.1M | ||
| Q3 25 | $-5.5M | $17.3M | ||
| Q2 25 | $-5.6M | $16.8M | ||
| Q1 25 | $-11.4M | $16.3M | ||
| Q4 24 | $9.6M | $16.2M | ||
| Q3 24 | $941.0K | $16.7M | ||
| Q2 24 | $-10.4M | $16.9M | ||
| Q1 24 | $-6.2M | $14.6M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 52.8% | ||
| Q3 25 | -17.6% | 62.8% | ||
| Q2 25 | -23.3% | 62.4% | ||
| Q1 25 | -36.1% | 61.3% | ||
| Q4 24 | 5.2% | 58.9% | ||
| Q3 24 | -8.2% | 61.4% | ||
| Q2 24 | -18.3% | 64.4% | ||
| Q1 24 | -23.9% | 62.6% |
| Q4 25 | -70.9% | 50.5% | ||
| Q3 25 | -10.5% | 45.5% | ||
| Q2 25 | -12.2% | 44.4% | ||
| Q1 25 | -27.5% | 45.3% | ||
| Q4 24 | 16.8% | 54.0% | ||
| Q3 24 | 1.8% | 45.3% | ||
| Q2 24 | -22.4% | 46.7% | ||
| Q1 24 | -13.8% | 44.8% |
| Q4 25 | — | $0.69 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.65 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.64 | ||
| Q3 24 | — | $0.65 | ||
| Q2 24 | — | $0.66 | ||
| Q1 24 | — | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $383.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $544.2M |
| Total Assets | $461.5M | $4.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $383.7M | ||
| Q3 25 | $93.3M | $227.2M | ||
| Q2 25 | $75.5M | $286.0M | ||
| Q1 25 | $95.3M | $285.1M | ||
| Q4 24 | $98.7M | $249.9M | ||
| Q3 24 | $162.3M | $291.2M | ||
| Q2 24 | $177.9M | $327.9M | ||
| Q1 24 | $168.8M | $258.8M |
| Q4 25 | $341.7M | $544.2M | ||
| Q3 25 | $378.6M | $445.9M | ||
| Q2 25 | $377.6M | $436.1M | ||
| Q1 25 | $379.6M | $428.0M | ||
| Q4 24 | $395.7M | $421.4M | ||
| Q3 24 | $385.5M | $407.2M | ||
| Q2 24 | $389.1M | $407.2M | ||
| Q1 24 | $392.6M | $396.6M |
| Q4 25 | $461.5M | $4.8B | ||
| Q3 25 | $494.9M | $3.6B | ||
| Q2 25 | $493.3M | $3.6B | ||
| Q1 25 | $482.6M | $3.7B | ||
| Q4 24 | $499.5M | $3.6B | ||
| Q3 24 | $491.2M | $3.6B | ||
| Q2 24 | $483.7M | $3.6B | ||
| Q1 24 | $492.1M | $3.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $37.7M |
| Free Cash FlowOCF − Capex | $-1.8M | $37.0M |
| FCF MarginFCF / Revenue | -2.9% | 84.7% |
| Capex IntensityCapex / Revenue | 1.6% | 1.5% |
| Cash ConversionOCF / Net Profit | — | 2.08× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $79.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $37.7M | ||
| Q3 25 | $-3.9M | $16.5M | ||
| Q2 25 | $108.0K | $14.5M | ||
| Q1 25 | $-125.0K | $11.9M | ||
| Q4 24 | $2.0M | $63.5M | ||
| Q3 24 | $13.2M | $-11.5M | ||
| Q2 24 | $6.2M | $19.4M | ||
| Q1 24 | $4.0M | $36.4M |
| Q4 25 | $-1.8M | $37.0M | ||
| Q3 25 | $-4.6M | $16.2M | ||
| Q2 25 | $-1.5M | $14.3M | ||
| Q1 25 | $-974.0K | $11.8M | ||
| Q4 24 | $1.1M | $62.2M | ||
| Q3 24 | $12.2M | $-11.8M | ||
| Q2 24 | $5.2M | $19.0M | ||
| Q1 24 | $3.4M | $36.1M |
| Q4 25 | -2.9% | 84.7% | ||
| Q3 25 | -8.7% | 42.7% | ||
| Q2 25 | -3.2% | 37.8% | ||
| Q1 25 | -2.3% | 32.9% | ||
| Q4 24 | 1.9% | 175.8% | ||
| Q3 24 | 23.7% | -31.9% | ||
| Q2 24 | 11.0% | 52.4% | ||
| Q1 24 | 7.6% | 110.6% |
| Q4 25 | 1.6% | 1.5% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 3.5% | 0.3% | ||
| Q1 25 | 2.0% | 0.2% | ||
| Q4 24 | 1.6% | 3.6% | ||
| Q3 24 | 2.0% | 0.8% | ||
| Q2 24 | 2.3% | 1.0% | ||
| Q1 24 | 1.3% | 0.7% |
| Q4 25 | — | 2.08× | ||
| Q3 25 | — | 0.95× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | 0.21× | 3.91× | ||
| Q3 24 | 14.05× | -0.69× | ||
| Q2 24 | — | 1.14× | ||
| Q1 24 | — | 2.49× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MCBS
Segment breakdown not available.
